Search

KR-20260062133-A - Transportation and intelligent management system for biopharmaceutical storage packaging using digital twin base

KR20260062133AKR 20260062133 AKR20260062133 AKR 20260062133AKR-20260062133-A

Abstract

The present invention relates to a transportation and intelligent management system for biological drug storage packaging based on a digital twin, which links information on biological drug cold chain packaging with a data logger to identify storage status in real time and respond appropriately, and enables virtual verification of the loading location of each package when transporting multiple packages to accurately identify them. The system comprises a user terminal with an app installed, a package in which a biological drug is stored and assigned a unique ID, a cold chain cloud that stores information about the package along with information about the package and transmits the internal temperature of the package, including location information about the package, to the user terminal in real time, a data logger that transmits information about the package to the cold chain cloud and receives instructions from an external source, and a control server that receives information about the package from the data logger via the cold chain cloud and monitors the cold chain. When multiple packages are loaded onto a transport vehicle for transportation, the control server receives information about the ID of the package and, through digital twin technology, It is characterized by displaying the mounting position for each package by creating a three-dimensional structure and transmitting it to the user terminal.

Inventors

  • 조수봉
  • 박지현
  • 고원진
  • 오민택

Assignees

  • 망고이즈 주식회사

Dates

Publication Date
20260507
Application Date
20241025

Claims (1)

  1. A user device with the app installed, and A package in which the biological drug is stored and assigned a unique ID, and A cold chain cloud that stores information about the biological drug stored in the package along with information about the package, and transmits the internal temperature of the package including location information about the package in real time to the user terminal, and A data logger that transmits information regarding the above packaging to the above cold chain cloud and receives instructions from an external source, and It comprises a control server that receives information about the packaging from the data logger via the cold chain cloud and monitors the cold chain, A transportation and intelligent management system for biological drug storage packaging based on a digital twin, characterized in that the control server receives information regarding the ID of the packaging when loading multiple packages onto a transport vehicle for transportation, visualizes them in three dimensions using digital twin technology, displays the loading location for each package, and transmits it to the user terminal.

Description

Transportation and intelligent management system for biopharmaceutical storage packaging using digital twin base The present invention relates to a cold chain system, and more specifically, to a transportation and intelligent management system for biological drug storage packaging using a digital twin, which synchronizes information on biological drug cold chain packaging with real-time monitoring by linking it with a data logger, and enables the virtual verification of the loading location of each package when transporting multiple packages, thereby allowing for accurate identification. Generally, a cold chain system is a low-temperature distribution system that ensures the quality and safety of goods by maintaining an appropriate temperature throughout the entire distribution process, from production and storage to transportation, sales, and delivery, for temperature-sensitive products such as agricultural, livestock, and seafood products, as well as flowers and pharmaceuticals. The essential purpose of the aforementioned cold chain system is to maintain the goods at a constant, appropriate temperature to extend their freshness and value. Since the cold chain is a supply chain that guarantees temperature maintenance, the entire system cannot be effective if even a single link is broken during the distribution process. However, with the exception of livestock products, Korea does not have certification standards for the entire process. Not only are there no standards for storage and transportation temperatures for each food item, but standards for containers and packaging have also not been established. Furthermore, due to the lack of certification and standardization for cold chain processes, users entrusting the transportation of temperature-sensitive products face significant difficulties in finding service providers. Consequently, there is a need for recommendations on optimal logistics packaging that comprehensively considers guaranteed temperature, temperature maintenance time, as well as reasonable pricing, insulation efficiency, and logistics efficiency. Recently, the need for a cold chain for biopharmaceuticals has been highlighted due to issues related to the distribution of influenza and COVID-19 vaccines. In other words, incidents involving the disposal of vaccines and the suspension of vaccinations occurred due to accidents in the distribution and storage of COVID-19 vaccines; for example, vaccines were replaced and discarded due to issues regarding temperature deviations during transportation and storage. Furthermore, although influenza vaccines are managed through a cold chain, leading to incidents such as the total disposal and suspension of vaccinations for vaccines exposed to room temperature, blind spots still existed. Most biological drugs are sensitive to temperature, and deviations from the approved storage temperature can significantly affect their efficacy, effectiveness, and safety. In addition, biological drugs that are discarded or returned due to temperature deviations can be fatal to patients' lives as they miss the appropriate time for treatment and prevention, and according to the World Health Organization (WHO), 50% of biological drugs worldwide are discarded every year due to the failure of cold chain systems. Therefore, a cold chain system is urgently needed to maintain storage conditions, such as temperature, and deliver biological products to the final consumption stage in order to guarantee their efficacy, effectiveness, and safety. Furthermore, health authorities in each country and international organizations are consistently presenting regulations and standards regarding the cold chain and further strengthening regulations. Currently, the pharmaceutical distribution sector in Korea ranks low in government policy, resulting in a lack of research on cold chain pharmaceutical distribution. Furthermore, surveys on the actual conditions of cold chain distribution environments by wholesalers are rarely conducted, and government guidelines or standards to manage and verify this are insufficient. Furthermore, the pharmaceutical cold chain differs from the distribution of general products in that it must prioritize quality control over cost reduction, and various research support and policy development are urgently required to advance the cold chain pharmaceutical industry. FIG. 1 is a schematic diagram showing the configuration of a transport and intelligent management system for biopharmaceutical storage packaging using a digital twin basis according to the present invention. FIG. 2 is a configuration diagram showing an intelligent vaccine cold chain monitoring system as an embodiment according to the present invention. FIGS. 3 and FIGS. 4 are a side plan view and an internal projection plan view implementing the packaging of FIG. 1. Figure 5 is a configuration diagram of a digital synchronization engine in which data from physical packaging is automatically reflected in th